Kankakee

1951 Ground broken for Kankakee Facility
1953 Kankakee Facility opened as Armour Laboratories
1958 Armour Pharmaceuticals provides human plasma, pharameuticals, and animal health products
1970 Greyhound obtains control of the Armour companies
1977 Revlon, Inc. purchases the Armour Pharmaceutical Company
1985 Expands biochemical business with responsibility for Meloy Laboratories
1987 Rorer Group acquires Armour Pharmaceuticals
1990 Rorer Group merges with Rhone-Poulenc S.A. to form Rhone-Poulenc Rorer
1996 Hoechst AG’s Behringwerke is merged with Armour Pharmaceuticals to form Centeon LLC
1999 Hoechst AG and Rhone-Poulenc Rorer merge to form Aventis SA
2000 Aventis SA changes name to Aventis Behring
2004 CSL Ltd. purchases Aventis Behring and forms ZLB Behring
2006 ZLB Behring changes name to CSL Behring

Building 21 is approved for production of expanded volumes of Zemaira®

Development of CSL’s ISCOMATRIX® adjuvant is a significant step in a new generation of vaccines in its ability to enhance human immune response to a vaccine.
2007 Afluria® influenza virus vaccine receives U.S. FDA approval
2009 Received U.S. FDA approval to fill, package and label Afluria®
2010 Multi-site Capacity Expansion begins. Expansion will allow the site to more than double its base fractionation and albumin capacity
2011 Begin producing DEAE eluate intermediate for the production of Beriplex® P/N

Ground breaking for Pi2 & KACE Project
2013 60th Anniversary Celebration. Marks 60 years of continuous operations

Construction is completed on new base fractionation facility, Building 30

New warehouse facility, Building 31, is released into operation. Building 31’s 3,000-square-foot storage freezer is the first stop for plasma as it arrives in Kankakee
2014 Ground breaking for Project Everest

FDA Approves Kankakee Intermediate for use in the Privigen® manufacturing process in Bern

FDA approves the manufacture of AlbuRx® in Kankakee
2015 Respreeza® approved in EU by the European Commission
2016 CSL Behring is recognized by OPTIONS Center for Independent Living for accessibility improvements made at its Kankakee, Illinois manufacturing site. OPTIONS partners with people living with disabilities who want to live independently and participate fully in society.